These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3175314)

  • 41. [Meta-analysis as a tool for gaining knowledge].
    Koch A; Ziegler S
    Med Klin (Munich); 2000 May; 95(1 Spec No):83-90. PubMed ID: 10851854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multilevel model framework for meta-analysis of clinical trials with binary outcomes.
    Turner RM; Omar RZ; Yang M; Goldstein H; Thompson SG
    Stat Med; 2000 Dec; 19(24):3417-32. PubMed ID: 11122505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demystifying optimal dynamic treatment regimes.
    Moodie EE; Richardson TS; Stephens DA
    Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analytic tools for medical decision making: a practical guide.
    Hasselblad V; McCrory DC
    Med Decis Making; 1995; 15(1):81-96. PubMed ID: 7898302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses.
    Al Khalaf MM; Thalib L; Doi SA
    J Clin Epidemiol; 2011 Feb; 64(2):119-23. PubMed ID: 20409685
    [No Abstract]   [Full Text] [Related]  

  • 46. Response adaptive designs with a variance-penalized criterion.
    Yi Y; Wang X
    Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five easy pieces on evidence-based medicine (4).
    Kalso E; Edwards J; McQuay HJ; Moore RA
    Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
    [No Abstract]   [Full Text] [Related]  

  • 48. Combining randomized and nonrandomized patients in the statistical analysis of clinical trials.
    Schumacher M; Davis K
    Recent Results Cancer Res; 1988; 111():130-7. PubMed ID: 3262903
    [No Abstract]   [Full Text] [Related]  

  • 49. Meta-STEPP with random effects.
    Wang XV; Cole B; Bonetti M; Gelber RD
    Res Synth Methods; 2018 Jun; 9(2):312-317. PubMed ID: 29281174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A note regarding meta-analysis of sequential trials with stopping for efficacy.
    Senn S
    Pharm Stat; 2014; 13(6):371-5. PubMed ID: 25296692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How can we make the results of trials and their meta-analyses using continuous outcomes clinically interpretable?
    Furukawa TA
    Acta Psychiatr Scand; 2014 Nov; 130(5):321-3. PubMed ID: 24725079
    [No Abstract]   [Full Text] [Related]  

  • 52. Quantifying the effect of the surrogate marker by information gain.
    Qu Y; Case M
    Biometrics; 2007 Sep; 63(3):958-62; author reply 962-3. PubMed ID: 17825025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating underlying risk as a source of heterogeneity in meta-analysis.
    Thompson SG; Smith TC; Sharp SJ
    Stat Med; 1997 Dec; 16(23):2741-58. PubMed ID: 9421873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analytic interval estimation for standardized and unstandardized mean differences.
    Bonett DG
    Psychol Methods; 2009 Sep; 14(3):225-38. PubMed ID: 19719359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generalized multidimensional dynamic allocation method.
    Lebowitsch J; Ge Y; Young B; Hu F
    Stat Med; 2012 Dec; 31(28):3537-44. PubMed ID: 22736449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reporting and interpreting results of systematic reviews.
    Harvey L; Wyndaele JJ
    Spinal Cord; 2009 Nov; 47(11):777. PubMed ID: 19890366
    [No Abstract]   [Full Text] [Related]  

  • 58. Statistical tools for subset analysis in clinical trials.
    Simon R
    Recent Results Cancer Res; 1988; 111():55-66. PubMed ID: 3051230
    [No Abstract]   [Full Text] [Related]  

  • 59. Detecting data fabrication in clinical trials from cluster analysis perspective.
    Wu X; Carlsson M
    Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Meta-analysis of clinical trials: values and limitations].
    Boissel JP
    Arch Mal Coeur Vaiss; 1994 Dec; 87 Spec No 4():11-7. PubMed ID: 7786131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.